REFERENCES
1. Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:623-8.
2. Klünemann M, Andrejev S, Blasche S, et al. Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 2021;597:533-8.
3. Coyte KZ, Schluter J, Foster KR. The ecology of the microbiome: networks, competition, and stability. Science 2015;350:663-6.
4. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.
5. Falony G, Joossens M, Vieira-Silva S, et al. Population-level analysis of gut microbiome variation. Science 2016;352:560-4.
6. Costea PI, Hildebrand F, Arumugam M, et al. Enterotypes in the landscape of gut microbial community composition. Nat Microbiol 2018;3:8-16.
7. Faith JJ, Guruge JL, Charbonneau M, et al. The long-term stability of the human gut microbiota. Science 2013;341:1237439.
8. Shaw LP, Bassam H, Barnes CP, Walker AS, Klein N, Balloux F. Modelling microbiome recovery after antibiotics using a stability landscape framework. ISME J 2019;13:1845-56.
9. Palleja A, Mikkelsen KH, Forslund SK, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol 2018;3:1255-65.
10. Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, et al. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng 2019;3:520-31.
11. Wilmes P, Bond PL. The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms. Environ Microbiol 2004;6:911-20.
12. Zhang X, Deeke SA, Ning Z, et al. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun 2018;9:2873.
13. Lehmann T, Schallert K, Vilchez-Vargas R, et al. Metaproteomics of fecal samples of Crohn’s disease and Ulcerative Colitis. J Proteomics 2019;201:93-103.
14. Long S, Yang Y, Shen C, et al. Metaproteomics characterizes human gut microbiome function in colorectal cancer. NPJ Biofilms Microbiomes 2020;6:14.
15. Zhong H, Ren H, Lu Y, et al. Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics. EBioMedicine 2019;47:373-83.
16. Chen Z, Li J, Gui S, et al. Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder. Neuroreport 2018;29:417-25.
17. Thuy-Boun PS, Mehta S, Gruening B, et al. Metaproteomics analysis of SARS-CoV-2-infected patient samples reveals presence of potential coinfecting microorganisms. J Proteome Res 2021;20:1451-4.
18. Li L, Ning Z, Zhang X, et al. RapidAIM: a culture- and metaproteomics-based Rapid Assay of Individual Microbiome responses to drugs. Microbiome 2020;8:33.
19. Li L, Abou-Samra E, Ning Z, et al. An in vitro model maintaining taxon-specific functional activities of the gut microbiome. Nat Commun 2019;10:4146.
20. Li L, Chang L, Zhang X, et al. Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes. Gut Microbes 2020;11:1348-61.
21. Li L, Ryan J, Ning Z, et al. A functional ecological network based on metaproteomics responses of individual gut microbiomes to resistant starches. Comput Struct Biotechnol J 2020;18:3833-42.
22. Sun Z, Wang W, Li L, et al. Comprehensive assessment of functional effects of commonly used sugar substitute sweeteners on ex vivo human gut microbiome. Microbiol Spectr 2022;10:e0041222.
23. Mayne J, Zhang X, Butcher J, et al. Examining the effects of an anti-salmonella bacteriophage preparation, BAFASAL®, on ex-vivo human gut microbiome composition and function using a multi-omics approach. Viruses 2021;13:1734.
24. Wang X, Sun G, Feng T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res 2019;29:787-803.
25. Le HH, Lee MT, Besler KR, Comrie JMC, Johnson EL. Characterization of interactions of dietary cholesterol with the murine and human gut microbiome. Nat Microbiol 2022;7:1390-403.
26. Liu H, Liao C, Wu L, et al. Ecological dynamics of the gut microbiome in response to dietary fiber. ISME J 2022;16:2040-55.
27. Argentini C, Mancabelli L, Alessandri G, et al. Exploring the ecological effects of naturally antibiotic-insensitive bifidobacteria in the recovery of the resilience of the gut microbiota during and after antibiotic treatment. Appl Environ Microbiol 2022;88:e0052222.
28. Lei C, Mu J, Teng Y, et al. Lemon exosome-like nanoparticles-manipulated probiotics protect mice from C. diff infection. iScience 2020;23:101571.
29. Zhang L, Elias JE. Relative protein quantification using tandem mass tag mass spectrometry. Methods Mol Biol 2017;1550:185-98.
30. Zecha J, Satpathy S, Kanashova T, et al. TMT labeling for the masses: a robust and cost-efficient, in-solution labeling approach. Mol Cell Proteomics 2019;18:1468-78.
31. Gonzalez CG, Wastyk HC, Topf M, Gardner CD, Sonnenburg JL, Elias JE. High-throughput stool metaproteomics: method and application to human specimens. mSystems 2020;5:e00200-20.
32. Burns AP, Zhang YQ, Xu T, et al. A universal and high-throughput proteomics sample preparation platform. Anal Chem 2021;93:8423-31.
33. Zhang X, Li L, Mayne J, Ning Z, Stintzi A, Figeys D. Assessing the impact of protein extraction methods for human gut metaproteomics. J Proteomics 2018;180:120-7.
34. Creskey M, Li L, Ning Z, et al. An economic and robust TMT labeling approach for high throughput proteomic and metaproteomic analysis. Proteomics 2023;23:e2200116.
35. Zhang X, Walker K, Mayne J, et al. Evaluating live microbiota biobanking using an ex vivo microbiome assay and metaproteomics. Gut Microbes 2022;14:2035658.
36. Li L, Zhang X, Ning Z, et al. Evaluating in vitro culture medium of gut microbiome with orthogonal experimental design and a metaproteomics approach. J Proteome Res 2018;17:154-63.
37. Li J, Jia H, Cai X, et al. MetaHIT Consortium. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014;32:834-41.
38. Huang T, Choi M, Tzouros M, et al. MSstatsTMT: statistical detection of differentially abundant proteins in experiments with isobaric labeling and multiple mixtures. Mol Cell Proteomics 2020;19:1706-23.
39. Li L, Ning Z, Cheng K, Zhang X, Simopoulos CMA, Figeys D. iMetaLab Suite: a one-stop toolset for metaproteomics. iMeta 2022;1:e25.
40. Čuklina J, Lee CH, Williams EG, et al. Diagnostics and correction of batch effects in large-scale proteomic studies: a tutorial. Mol Syst Biol 2021;17:e10240.
